MDCM
DGX icon

Morgan Dempsey Capital Management’s Quest Diagnostics DGX Stock Holding History

Morgan Dempsey Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-345
Closed -$20K – 165
2014
Q1 		$20K Sell
345
-110
-24% -$5.9K 0.01% 163
2013
Q4 		$24K Sell
455
-2,390
-84% -$142K 0.01% 169
2013
Q3 		$176K Sell
2,845
-1,150
-29% -$68.8K 0.06% 128
2013
Q2 		$242K Buy
+3,995
New +$238K 0.09% 121

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Dempsey Capital Management's DGX Position: Q2 2014 in Review

Morgan Dempsey Capital Management sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 345 shares — an estimated $20K sold.

Morgan Dempsey Capital Management first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $242K in Q2 2013. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • Morgan Dempsey Capital Management reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 345 Quest Diagnostics shares in Q2 2014, an estimated $20K.
  • Morgan Dempsey Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • Morgan Dempsey Capital Management's Quest Diagnostics position peaked at $242K in Q2 2013.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Morgan Dempsey Capital Management's 13F filing for Q2 2014, filed 15 Jul 2014.